Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board With today being the first day of May, Brain Tumor Awareness Month, I wish to highlight for you a recently produced set of best practices and guidelines pertaining to brain cancer and COVID-19. Glioblastoma, also known as glioblastoma multiforme (GBM), is the…...
Infection Threat from Asymptomatic COVID-19 Patients Around You
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The recently announced extension of social distancing guidelines through the end of April is an important step taken by the U.S. federal government to slow down the spread of coronavirus. But the overall picture of the COVID-19 pandemic is still very…...
‘Should I Continue my Scheduled Cancer Treatment During the Coronavirus Pandemic?’ And Other Questions Answered
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The total number of confirmed COVID-19 cases worldwide has surpassed 1.4 million. With varying public health responses across countries, there is still no clear prediction for when the number of cases will peak. This severe situation creates challenges for cancer patients…...
What Should Cancer Patients Do to Prevent COVID-19 Infection?
Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The pandemic associated with coronavirus disease COVID-19 is particularly dangerous for someone with cancer, whose body’s primary defense mechanism, the human immune system, is weaker than that of a healthy person. Simply put, so-called immunosuppressed individuals are at higher risk of…...
- 1
- 2
